Netherlands, Utrecht (NL)

Pharmaceutical Policy Analysis

when 13 July 2015 - 17 July 2015
duration 1 week
credits 1.5 ECTS
fee EUR 1150

Medicines are among the most regulated products in society. A drug reaching the market is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.
The aim of the course is to give insight into current developments in pharmaceutical policy making and to give a better understanding of the methods for analysing the effects of policy interventions. As a collaborator, the World Health Organization will provide faculty for several sessions.

Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.

You will experience an intensive programme covering the following topics:
Pharmaceutical Policy Analysis issues and methods; current challenges in drug innovation; universal health coverage; regulatory issues and challenges; country profiles; policy and politics; synthesis, case studies & public health.

Course leader

Dr. Aukje Mantel-Teeuwisse

Target group

(Post)graduates and professionals within governments, NGOs, industry, universities
with a basic knowledge public health/medicine who have an interest in the policy
aspects of pharmaceuticals.

Course aim

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course,
the World Health Organization will provide faculty for several of the sessions.
You will experience an intensive programme covering the following topics:
Pharmaceutical Policy Analysis issues and methods; current challenges in drug innovation; universal health coverage; regulatory issues and challenges; country profiles; policy and politics; synthesis, case studies & public health.

Credits info

1.5 ECTS
Certificate of attendance

Fee info

EUR 1150: Course + course materials + housing

The course fee includes coffee, tea, lunches, course materials and one course dinner. This course can be combined with course M8 (Pharmacoepidemiology & Drug Safety) and/or M14 (Pharmacoeconomics). Combination fee for two courses is €1500,- (excluding housing), combination fee for all three courses combined is €1950,- (excluding housing)
EUR 950: Course + course materials

Scholarships

Utrecht Summer School doesn't offer scholarships for this course.

Register for this course
on course website